Condition
Mass Lesion
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting2
Completed1
Terminated1
Unknown1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07228689Recruiting
AI for Onsite Cytology Evaluation in Endoscopic Ultrasound
NCT04764396Not ApplicableTerminated
Assessing Effects of Heparin Priming and Pass Number on Tissue Quality of Fine Needle Biopsies
NCT06027411Recruiting
Assess the Clinical Effectiveness in AI Prioritising CT Heads
NCT03674710Not ApplicableUnknown
A Multi-center, Prospective, Single-blind, Controlled Trial Comparing Diagnostic Value of Different EUS-FNA Techniques
NCT02133417CompletedPrimary
Non-Inferiority Quantitative Transmission Ultrasound Case Collection Study
Showing all 5 trials